Clinical Trial Update: Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment With Fluvoxamine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating cognitive functioning in individuals with recurrent major depressive disorder who are remitted and treated with fluvoxa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder Recurrent

Drugs mentioned

• Fluvoxamine (fluvoxamine)

Snippet

Sponsor: Moscow Research Institute of Psychiatry | Conditions: Recurrent Depressive Disorder | Phase 4 | Status: COMPLETED